Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: corticosteroids

Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors

Jonida Cote, DO, Thomas Harrington, MD, Alicia Meadows, DO, Fan Lin, MD, and Androniki Bili, MD, MPH  |  November 1, 2013

Two patients with psoriatic arthritis treated with TNF-alpha inhibitor therapy develop the multisystem disease

Filed under:ConditionsOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:Psoriatic ArthritisSarcoidosisTherapiesTreatmentTumor Necrosis Factor–Alpha Inhibitor

John F. Kennedy’s Odyssey in Search of Diagnosis

Simon M. Helfgott, MD  |  November 1, 2013

Myriad health conditions from back pain to gastrointestinal illness plagued the late president and baffled his physicians

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:DiagnosisRheumatic Disease

New Insights into CPPD

Robert Terkeltaub, MD  |  October 1, 2013

Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:DiseaseResearchTreatment

Dermatology Case Answer B: September

Alisa Femia, MD and Joseph F. Merola, MD  |  September 18, 2013

Foot rash on man with hypertension

Filed under:ConditionsVasculitis Tagged with:Dermatologyfoot rashhypertension

Letters: Remembering Rheumatology Pioneer Dr. Robert M. Stecher

Staff  |  September 1, 2013

Acclaimed rheumatologist is known for research on the effects of corticosteroids on rheumatoid arthritis and the role of genetics in rheumatic disease

Filed under:Professional TopicsProfiles Tagged with:rheumatology

ACR 2013 State-of-the-Art Clinical Symposium: The Challenge of Treating Low Back Pain

Kathy Holliman  |  August 1, 2013

With no single therapy effective for chronic low back pain, physicians must try multiple therapeutic approaches, nonsurgical options

Filed under:Axial SpondyloarthritisConditionsMeeting Reports Tagged with:AC&Rlow back painnonsurgicaltherapyTreatment

ACR 2013 State-of-the-Art Clinical Symposium: What’s Next in Therapy for Osteoarthritis, Rheumatoid Arthritis, and Lupus?

Kathy Holliman  |  August 1, 2013

Experts highlight treatment advances and challenges ahead in OA, RA, and systemic lupus erythematosus (SLE)

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RLupusOsteoarthritisRheumatoid arthritisSLETreatment

Congress Considers More Regulation for Manufacturers of Compounding Drugs

Richard Quinn  |  July 22, 2013

New legislation would place manufacturers of compounding drugs under FDA supervision. (posted July 22, 2013)

Filed under:Legislation & Advocacy Tagged with:FDA

California Rheumatology Alliance 2013 Meeting: Rheumatologists Advised to Drop Prednisone Maintenance Therapy in Lupus Patients

Stephanie Cajigal  |  July 1, 2013

A systemic lupus erythematosus (SLE) disease expert emphasizes benefits of hydroxychloroquine, burst of steroid treatments

Filed under:ConditionsDrug UpdatesSystemic Lupus Erythematosus Tagged with:HYDROXYCHLOROQUINELupusprednisoneSLETreatment

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Drug Updates Tagged with:ApprovalsglucosamineopioidPipelineSafety

  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 44
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences